Annals of Oncology Advance Access originally published online on April 2, 2008
Annals of Oncology 2008 19(6):1203-1204; doi:10.1093/annonc/mdn156
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2008. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org
letters |
The potential role of positron emission tomography in the detection of occult cancer in 25 patients with venous thromboembolism
| The first 10% of the full text of this article appears below. |
Screening for occult cancer in patients with idiopathic venous thromboembolism (VTE) remains a major unresolved issue with respect to extensiveness and costs of investigations [1, 2]. The highly sensitive whole body, 18F-fluoro-2-deoxy-D-glucose positron emission
1 Department of Internal Medicine
2 Department of Nuclear Medicine, St Antonius Hospital, Nieuwegein
3 Department of Epidemiology, University of Maastricht, Maastricht
4 Department of Internal Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands
* (E-mail: mmjbeckers@yahoo.com)